Status: Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
Participants needed: 325
Trial details
Phase: Phase 2, Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Kiniksa Pharmaceuticals International, plcUpdated: Aug 11, 2026Locations: 62
Eligibility criteria
Phase 2 and 3: Has a diagnosis of recurrent pericarditis [+4]
Phase 2 and 3: Has a diagnosis of pericarditis that is secondary to specific pro... [+10]